Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock’s sell-off is excessive.
Latest Ratings for VKTX
DateFirmActionFromTo Feb 2022Raymond JamesMaintainsOutperform Jul 2021Raymond JamesMaintainsOutperform May 2021Raymond JamesDowngradesStrong BuyOutperform